Publikationen in Zusammenarbeit mit Forschern von University of Turin (3)

2019

  1. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Oncology, Vol. 20, Núm. 12, pp. 1655-1669

2018

  1. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

    The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781

2016

  1. BRAF mutations in non-small cell lung cancer: Has finally Janus opened the door?

    Critical Reviews in Oncology/Hematology, Vol. 101, pp. 32-39